Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Synovitis, Pigmented Villonodular × cabiralizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 2 Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Synovitis, Pigmented Villonodular 1 Ovarian Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Glioma 1 Giant Cell Tumor of Tendon Sheath 1 Carcinoma, Hepatocellular 1 Advanced Pancreatic Cancer 1 Advanced Malignancies 1

Interventions

pexidartinib 3 nilotinib 2 emactuzumab 1 cabiralizumab 1 Tolbutamide 1 Midazolam 1 Bro protein, Drosophila 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471716 2021-08-31

FPA008-002

Five Prime Therapeutics, Inc.

Phase 1/2 Completed

66 enrolled 20 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡